Sanofi, GSK Ink $2.1B Covid-19 Vaccine Deal From US Government

French drugmaker Sanofi (SNYNF) and GlaxoSmithKline (GSK) will be granted up to $2.1 billion by the U.S. government for the development of their coronavirus vaccine candidate, including clinical tria…
Read More